GeneDx to Present Data at the 2024 American College of Medical Genetics (ACMG) Annual Meeting Demonstrating Clinical Superiority of its Exome, Paving the Way for the Future of Genomics

March 14, 2024

https://www.globenewswire.com/news-release/2024/03/14/2846277/0/en/GeneDx-to-Present-Data-at-the-2024-American-College-of-Medical-Genetics-ACMG-Annual-Meeting-Demonstrating-Clinical-Superiority-of-its-Exome-Paving-the-Way-for-the-Future-of-Genomic.html

STAMFORD, Conn., March 14, 2024 (GLOBE NEWSWIRE) — GeneDx (Nasdaq:WGS), a leader in delivering improved health outcomes through genomic insights, today announced its scientific contributions at the 2024 American College of Medical Genetics and Genomics (ACMG) Annual Clinical Genetics Meeting. Across one platform presentation, an industry symposium and six poster presentations, including one selected as a “Rapid Fire Poster Session,” an invitation-only presentation of the top 20 ACMG posters, GeneDx continues to demonstrate its industry leadership in shaping the future landscape of genomics.

Read more at globenewswire.com

NASDAQ and NYSE quotes and data are delayed 15 minutes unless indicated otherwise. Market data and exchange information are provided for informational purposes only and is not intended for trading purposes. Neither 24/7 Market News Editors, 247 Market News, or data and content providers shall be liable for any errors or omissions, delays, misquotes or other market information relayed in any press materials. You should Use Realtime data to conduct due diligence before investing or trading, and trading in any stock is risky you could lose all your money.